Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001493152-22-036373

Options or other derivatives

  • Chief Executive Officer acquired 112,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Mahesh V. Chief Executive Officer 2022-12-22 Grant or award · Stock Option (Right to Buy) +112,500 $0.41 $46,125 2,242,395 D
Loading xslF345X03/ownership.xml…